Inherited neutropenia syndromes, severe congenital neutropenia (CN) and Shwachman-Diamond syndrome (SDS), confer a high cumulative risk of MDS and AML. It is not yet clear which somatic mutations, in which combination, allele frequency and sequence identify patients at high risk. We analyzed clonal hematopoiesis (CH) i...
M. Klimiankou, S. Kandabarau, C. Zeidler et al.· bioRxiv· 0 citations
, disease modelling and genomic/immunological characterization, may collectively advance the safe and effective clinical translation of iPSC-derived cell products.
B. Álvarez-Palomo, Julia Skokowa, Helen Latsoudis· Frontiers in Immunology· 0 citations
Key applications of iPSC technology in hemato-oncology are summarized, its major advantages and current limitations are discussed, and emerging directions are highlighted, including scalable iPSC-derived blood cell therapies for inherited and acquired bone marrow failure syndromes and leukemia.
Ivan Tesakov, M. Nasri, M. Klimiankou et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.